Process for preparation of 1-(2S,3S)-2-benzhydr ylN- (5-tert-butyl-2-methoxybenzyl)quinuclidi n-3-amine

Details for Australian Patent Application No. 2005210259 (hide)

Owner Pfizer Products Inc.

Inventors Post, Ronald James; Taber, Geraldine Patricia; Basford, Patricia Ann; Smith, Julian Duncan

Agent Shelston IP

Pub. Number AU-A-2005210259

PCT Pub. Number WO2005/075473

Priority 60/541,323 02.02.04 US

Filing date 26 January 2005

Wipo publication date 18 August 2005

International Classifications

C07D 453/02 (2006.01) Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids

Event Publications

10 August 2006 PCT application entered the National Phase

  PCT publication WO2005/075473 Priority application(s): WO2005/075473

19 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005210265-Co-production of hydrocarbons and dimethyl ether

2005210254-Pyridinyl - or pyrimidinyl thiazoles with protein kinase inhibiting activity